A project to reduce the burden of diabetes in the African-American community: Project direct

Journal of the National Medical Association

Volumn 90, Issue 10, 1998, Pages 605-613

  Engelgau, Michael M ^a   Narayan, K M Venkat ^b   Geiss, Linda S ^b   Thompson, Theodore J ^b   Beckles, Gloria L A ^b   Lopez, Laureen ^b   Hartwell, Tyler ^b   Visscher, Wendy ^b   Liburd, Leandris ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NONE

Author keywords

Community intervention; Diabetes mellitus; Health promotion; Project DIRECT; Quality of care

Indexed keywords

AFRICAN AMERICAN; ARTICLE; COMMUNITY CARE; DIABETES MELLITUS; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT; UNITED STATES;

AFRICAN AMERICANS; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; NORTH CAROLINA; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 0032186055     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tull ES, Roseman JM. Diabetes in African Americans. In: Harris MI, ed. Diabetes in America. 2nd ed. Washington DC: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:613-630. NIH publication 95-1468.
2. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974;78:58-67.
3. Harris MI. Noninsulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab. 1990;6:71-90.
4. Eggers PW, Connerton R, McMullen M. Health Care Financing Rev. 1984;5:69-88.
5. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;306:1074-1079.
6. Rostand SG, Kirk RA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276-1282.
7. Smith SR, Svetkey LP, Dennis VW. Racial differences in the incidence and progression of renal diseases. Kidney Int. 1991;40:815-822.
8. Centers for Disease Control and Prevention. Diabetes Surveillance, 1993. Atlanta, Ga: US Department of Health and Human Services; 1993.
9. Allen TB, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin treated patients with type 11 diabetes mellitus. Diabetes Care. 1990;13:1044-1050.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
11. Litzelman DK, Slemenda CW, Langefeld DC, Hays LM, Welch MA, Bild PE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin dependent diabetes mellitus. Ann Intern Med. 1993;119:36-41.
12. Ferris FL. How effective are treatments for diabetic retinopathy? JAMA. 1993;269:1290-1291.
13. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-620.
14. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The DaZing IGT and diabetes study. Diabetes Care. 1997;20:537-544.
15. Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, et al. Preventing non-insulin-dependent diabetes. Diabetes. 1995;44:483-488.
16. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32-38.
17. Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Maskell WL, Williams PT, et al. Effects of community wide education on the cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990;264:359-365.
18. Luepker RV, Murray DM, Jacobs DR, Mittelmark MB, Bracht N, Carlaw R, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Health Program. Am J Public Health. 1994;84:1383-1393.
19. Carleton RA, Lasater TM, Assaf AR, Feldman HA, McKinlay S. The Pawtucket Heart Health Program: community changes in cardiovascular risk; factors and projected disease risk. Am J Public Health. 1995;85:777-785.
20. COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT), II: changes in adult cigarette smoking prevalence. Am J Public Health. 1995;85:193-200.
21. Feinleib M. New directions for community intervention studies. Am J Public Health. 1996;86:1696-1698. (Editorial)
22. Herman WH, Thompson TJ, Visscher W, Aubert RE, Engelgau MM, Liburd L, et al. Diabetes mellitus and its complications in an African-American community: Project DIRECT. J Natl Med Assoc. 1998;90:147-156.
23. Manson JE, Rimm EB, Stampfer MJ, Coldita GA, Willett WC, Krowlewski AS, et al. Physical activity and incidence of noninsulin-dependent diabetes mellitus in women. Lancet. 1991;338:774-778.
24. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991;325:147-152.
25. Manson FE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA. 1992;268:63-67.
26. World Health Organization Study Group on Prevention of Diabetes Mellitus. Prevention of Diabetes Mellitus. World Health Organ Tech Rep Ser. 1994;844:25-40.
27. American Diabetes Association. Position statement: screening for diabetes. Diabetes Care. 1989;12:588-590.
28. Patterson KR. Population screening for diabetes mellitus. Diabet Med. 1993;10:77-81.
29. Reichard P, Nelsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993;329:304-309.
30. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258-268.
31. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
32. Centers for Disease Control and Prevention. Trends in the prevalence and incidence of self-reported diabetes mellitus-United States, 1980-1994. MMWR Morb Mortal Wkly Rep. 1997;46:1014-1018.
33. National Society to Prevent Blindness. Vision Problems in the US. Data Analysis, Definitions, Data Sources, Detailed Data Tables, Analyses, Interpretations. New York, NY: National Society to Prevent Blindness; 1980.
34. American Diabetes Association. Direct and Indirect Costs of Diabetes in the United States in 1992. Alexandria, Va: American Diabetes Association; 1993.
35. US Department of Health and Human Services, Public Health Service. Healthy People 2000. National Health Promotion and Disease Prevention Objectives. Washington, DC: US Dept of Health and Human Services; 1991. Publication (PHS) 91-50212.